Scholar Rock Holding Corporation, a late-stage biopharmaceutical company, is set to participate in the 46th Annual Goldman Sachs Global Healthcare Conference. The event, taking place on Wednesday, June 11 at 9:20 a.m. ET in Miami, Florida, will feature a fireside chat with CEO David L. Hallal and members of the management team. They will discuss the company's focus on developing and commercializing apitegromab for patients with spinal muscular atrophy $(SMA)$ and other severe neuromuscular diseases.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。